Insulet

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Insulet 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PODD

Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. 

CEO
Ashley A. McEvoy
CEOAshley A. McEvoy
Employees
5,400
Employees5,400
Headquarters
Acton, Massachusetts
HeadquartersActon, Massachusetts
Founded
2000
Founded2000
Employees
5,400
Employees5,400

PODD Key Statistics

Market cap
13.90B
Market cap13.90B
Price-Earnings ratio
56.60
Price-Earnings ratio56.60
Dividend yield
Dividend yield
Average volume
888.63K
Average volume888.63K
High today
$198.46
High today$198.46
Low today
$194.61
Low today$194.61
Open price
$196.23
Open price$196.23
Volume
211.28K
Volume211.28K
52 Week high
$354.88
52 Week high$354.88
52 Week low
$194.61
52 Week low$194.61

Stock Snapshot

With a market cap of 13.9B, Insulet(PODD) trades at $197.43. The stock has a price-to-earnings ratio of 56.60.

During the trading session on 2026-04-13, Insulet(PODD) shares reached a daily high of $198.46 and a low of $194.61. At a current price of $197.43, the stock is +1.4% higher than the low and still -0.5% under the high.

Trading activity shows a volume of 211.28K, compared to an average daily volume of 888.63K.

Over the past 52 weeks, Insulet(PODD) stock has traded between a high of $354.88 and a low of $194.61.

Over the past 52 weeks, Insulet(PODD) stock has traded between a high of $354.88 and a low of $194.61.

PODD News

TipRanks 6d
Insulet downgraded to Neutral from Buy at Citi

Citi downgraded Insulet (PODD) to Neutral from Buy with a price target of $230, down from $338, ahead of the Q1 report. The firm cites increasing patch pump com...

Analyst ratings

89%

of 27 ratings
Buy
88.9%
Hold
7.4%
Sell
3.7%

People also own

Based on the portfolios of people who own PODD. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.